Medicine containing polysacccharide substances for activating apoptosis
OwnerJean-Claude Yvin, Andre Patrick Arrigoinventors
Life of this patent
Estimating the term…
Abstract
The invention concerns the use of at least a polysaccharide substance having at least five saccharide units and comprising at least some single-unit motifs thereof, at least a substituent bearing at least a negative charge selected among the group comprising in particular the sulphate, acetate, phosphate, phosphonate groups, for preparing a medicine for activating apoptosis by increasing the number of apoptosis receptors at the cell surface, said receptors being those of the group comprising Fas, TNF, TRAIL, CD40, preferably Fas and TNF, receptors.
Claims13
The use of at least one polysaccharide substance having at least five saccharide units and comprising, on at least some of its individual units, at least one substituent carrying at least one negative charge, chosen from the group comprising in particular sulfate, acetate, phosphate and phosphonate groups, for preparing a medicine for activating apoptosis by increasing the number of apoptosis receptors at the cell surface, said receptors being those of the group comprising Fas, TNF, TRAIL and CD40 receptors, preferably Fas receptors.
Dependencies are inferred from the claim text.